Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Current methods to deliver bacteria to the bladder are invasive and require repeated catheter insertion. Even when bacteria ...

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

It’s a finding that is associated with many diseases, and treatment depends on the exact cause. Colitis can be due to ...